(AALB) Aalberts Industries - Overview

Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: AS (Netherlands) | Market Cap: 4.143m EUR | Total Return: 32.3% in 12m

Piping Systems, Flow Control, Mechatronics, Surface Treatments
Total Rating 61
Safety 91
Buy Signal 0.56
Specialty Industrial Machinery
Industry Rotation: -8.7
Market Cap: 4.82B
Avg Turnover: 8.69M
Risk 3d forecast
Volatility35.6%
VaR 5th Pctl5.62%
VaR vs Median-4.62%
Reward TTM
Sharpe Ratio0.80
Rel. Str. IBD78.8
Rel. Str. Peer Group72.3
Character TTM
Beta0.723
Beta Downside0.501
Hurst Exponent0.435
Drawdowns 3y
Max DD44.75%
CAGR/Max DD0.02
CAGR/Mean DD0.05

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: AALB Aalberts Industries

Aalberts N.V. is a Netherlands-based industrial technology company specializing in mission-critical systems for the building, industrial, and semiconductor sectors. The company operates through four primary technology clusters: hydronic flow control, integrated piping systems, advanced mechatronics, and surface technologies. Its business model focuses on engineering high-specification components, such as vibration isolation systems and high-purity fluid delivery, which are essential for precision manufacturing environments.

The company serves a global market across Europe, the Americas, and Asia, utilizing a portfolio of established brands including BROEN and Henco. Operating within the industrial machinery sector, Aalberts benefits from structural demand in energy-efficient construction and the increasing technical requirements of the global semiconductor supply chain. Investors can further analyze these market dynamics and valuation metrics on ValueRay.

Headlines to Watch Out For
  • Global semiconductor equipment demand drives high-margin mechatronics and fluid system revenue
  • European energy efficiency regulations stimulate demand for hydronic flow control systems
  • Rising construction costs and interest rates impact building segment volume growth
  • Industrial surface technology margins fluctuate based on European energy and labor costs
  • Strategic acquisitions and portfolio optimization accelerate long-term recurring revenue expansion
Piotroski VR-10 (Strict) 8.0
Net Income: 267.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.09 > 0.02 and ΔFCF/TA 4.41 > 1.0
NWC/Revenue: 8.38% < 20% (prev 10.84%; Δ -2.46% < -1%)
CFO/TA 0.19 > 3% & CFO 807.6m > Net Income 267.8m
Net Debt (1.30b) to EBITDA (842.6m): 1.55 < 3
Current Ratio: 1.52 > 1.5 & < 3
Outstanding Shares: last quarter (109.0m) vs 12m ago -1.45% < -2%
Gross Margin: 41.72% > 18% (prev 0.28%; Δ 4.14k% > 0.5%)
Asset Turnover: 129.1% > 50% (prev 119.4%; Δ 9.69% > 0%)
Interest Coverage Ratio: 5.82 > 6 (EBITDA TTM 842.6m / Interest Expense TTM 79.6m)
Altman Z'' 4.39
A: 0.11 (Total Current Assets 1.33b - Total Current Liabilities 874.0m) / Total Assets 4.32b
B: 0.53 (Retained Earnings 2.29b / Total Assets 4.32b)
C: 0.11 (EBIT TTM 463.5m / Avg Total Assets 4.23b)
D: 1.17 (Book Value of Equity 2.23b / Total Liabilities 1.90b)
Altman-Z'' = 4.39 = AA
Beneish M -3.47
DSRI: 0.83 (Receivables 359.8m/392.4m, Revenue 5.46b/4.94b)
GMI: 0.68 (GM 41.72% / 28.47%)
AQI: 1.07 (AQ_t 0.38 / AQ_t-1 0.35)
SGI: 1.11 (Revenue 5.46b / 4.94b)
TATA: -0.12 (NI 267.8m - CFO 807.6m) / TA 4.32b)
Beneish M = -3.47 (Cap -4..+1) = AA
What is the price of AALB shares?

As of May 25, 2026, the stock is trading at EUR 38.76 with a total of 399,553 shares traded.
Over the past week, the price has changed by +6.19%, over one month by +22.50%, over three months by +18.70% and over the past year by +32.30%.

Is AALB a buy, sell or hold?

Aalberts Industries has no consensus analysts rating.

Aalberts Industries (AALB) - Fundamental Data Overview as of 24 May 2026
Market Cap USD = 4.82b (4.14b EUR * 1.1641 EUR.USD)
P/E Trailing = 28.5
P/E Forward = 13.6054
P/S = 1.3404
P/B = 1.7091
P/EG = 1.3182
Revenue TTM = 5.46b EUR
EBIT TTM = 463.5m EUR
EBITDA TTM = 842.6m EUR
Long Term Debt = 700.9m EUR (from longTermDebt, last quarter)
Short Term Debt = 259.4m EUR (from shortTermDebt, last quarter)
Debt = 1.42b EUR (from shortLongTermDebtTotal, last quarter) + Leases 183.1m
Net Debt = 1.30b EUR (calculated: Debt 1.42b - CCE 121.6m)
Enterprise Value = 5.44b EUR (4.14b + Debt 1.42b - CCE 121.6m)
Interest Coverage Ratio = 5.82 (Ebit TTM 463.5m / Interest Expense TTM 79.6m)
EV/FCF = 14.79x (Enterprise Value 5.44b / FCF TTM 368.1m)
FCF Yield = 6.76% (FCF TTM 368.1m / Enterprise Value 5.44b)
FCF Margin = 6.74% (FCF TTM 368.1m / Revenue TTM 5.46b)
Net Margin = 4.90% (Net Income TTM 267.8m / Revenue TTM 5.46b)
Gross Margin = 41.72% ((Revenue TTM 5.46b - Cost of Revenue TTM 3.18b) / Revenue TTM)
Gross Margin QoQ = 24.26% (prev 63.35%)
Tobins Q-Ratio = 1.26 (Enterprise Value 5.44b / Total Assets 4.32b)
Interest Expense / Debt = 5.59% (Interest Expense 79.6m / Debt 1.42b)
Taxrate = 42.61% (21.9m / 51.4m)
NOPAT = 266.0m (EBIT 463.5m * (1 - 42.61%))
Current Ratio = 1.52 (Total Current Assets 1.33b / Total Current Liabilities 874.0m)
Debt / Equity = 0.59 (Debt 1.42b / totalStockholderEquity, last quarter 2.42b)
Debt / EBITDA = 1.55 (Net Debt 1.30b / EBITDA 842.6m)
Debt / FCF = 3.54 (Net Debt 1.30b / FCF TTM 368.1m)
Total Stockholder Equity = 2.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.33% (Net Income 267.8m / Total Assets 4.32b)
RoE = 10.85% (Net Income TTM 267.8m / Total Stockholder Equity 2.47b)
RoCE = 14.62% (EBIT 463.5m / Capital Employed (Equity 2.47b + L.T.Debt 700.9m))
RoIC = 7.41% (NOPAT 266.0m / Invested Capital 3.59b)
WACC = 7.17% (E(4.14b)/V(5.57b) * Re(8.53%) + D(1.42b)/V(5.57b) * Rd(5.59%) * (1-Tc(0.43)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -59.68 | Cagr: -0.65%
[DCF] Terminal Value 77.97% ; FCFF base≈288.8m ; Y1≈331.0m ; Y5≈487.2m
[DCF] Fair Price = 56.41 (EV 7.33b - Net Debt 1.30b = Equity 6.03b / Shares 106.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -52.17 | EPS CAGR: -14.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: -88.18 | Revenue CAGR: -15.49% | SUE: 0.00 | # QB: 0
EPS current Year (2026-12-31): EPS=2.81 | Chg30d=+0.83% | Revisions=+25% | GrowthEPS=+8.0% | GrowthRev=-4.0%
EPS next Year (2027-12-31): EPS=3.14 | Chg30d=+1.33% | Revisions=+25% | GrowthEPS=+11.7% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +25%